Ram K. Dhaked

Jhansi Road
Gwalior, MP 474002, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Targeting the Enzymatic Site of Botulinum Neurotoxin Type E With 8-Hydroxyquinolinol-Based Inhibitors: In Silico, In Vitro, and In Vivo Evaluation.

Targeting the Enzymatic Site of Botulinum Neurotoxin Type E With 8-Hydroxyquinolinol-Based Inhibitors: In Silico, In Vitro, and In Vivo Evaluation.

Journal: Drug development research

Published: May 02, 2025

A battery of assays for chasing ricin and its activity.

A battery of assays for chasing ricin and its activity.

Journal: Toxicology letters

Published: July 10, 2024

Development and validation of streptavidin-biotin-based double antibody sandwich ELISA for ricin diagnosis.

Development and validation of streptavidin-biotin-based double antibody sandwich ELISA for ricin diagnosis.

Journal: International immunopharmacology

Published: October 09, 2023

Designing, synthesis and evaluation of derived analogues of selected small molecule non-peptidic inhibitors against serotype BoNT/ F.

Designing, synthesis and evaluation of derived analogues of selected small molecule non-peptidic inhibitors against serotype BoNT/ F.

Journal: Toxicon : official journal of the International Society on Toxinology

Published: June 24, 2022

Silibinin ameliorates abrin induced hepatotoxicity by attenuating oxidative stress, inflammation and inhibiting Fas pathway.

Silibinin ameliorates abrin induced hepatotoxicity by attenuating oxidative stress, inflammation and inhibiting Fas pathway.

Journal: Environmental toxicology and pharmacology

Published: November 10, 2021

E-N-(2-acetyl-phenyl)-3-phenyl-acrylamide targets abrin and ricin toxicity: Hitting two toxins with one stone.

E-N-(2-acetyl-phenyl)-3-phenyl-acrylamide targets abrin and ricin toxicity: Hitting two toxins with one stone.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 03, 2021

Characterization of immune response induced against catalytic domain of botulinum neurotoxin type E.

Characterization of immune response induced against catalytic domain of botulinum neurotoxin type E.

Journal: Scientific reports

Published: January 20, 2020

Immunological detection assays for recombinant Shiga toxin & Shigella dysenteriae.

Immunological detection assays for recombinant Shiga toxin & Shigella dysenteriae.

Journal: The Indian journal of medical research

Published: June 29, 2019

Targeted 8-hydroxyquinoline fragment based small molecule drug discovery against neglected botulinum neurotoxin type F.

Targeted 8-hydroxyquinoline fragment based small molecule drug discovery against neglected botulinum neurotoxin type F.

Journal: Bioorganic chemistry

Published: April 29, 2019

Biochemical Characterization of In vitro Reconstituted Biologically Active Recombinant Shiga Toxin.

Biochemical Characterization of In vitro Reconstituted Biologically Active Recombinant Shiga Toxin.

Journal: Protein and peptide letters

Published: October 23, 2018

Identification of Inhibitors against Botulinum Neurotoxins: 8-Hydroxyquinolines Hold Promise.

Identification of Inhibitors against Botulinum Neurotoxins: 8-Hydroxyquinolines Hold Promise.

Journal: Mini reviews in medicinal chemistry

Published: September 03, 2018

High level expression and immunochemical characterization of botulinum neurotoxin type F light chain.

High level expression and immunochemical characterization of botulinum neurotoxin type F light chain.

Journal: Protein expression and purification

Published: December 01, 2017

Showing 1-12 of 17

Last Updated: 09/26/2026